Climate Change Data

Environmental Metrics

ESG Focus Areas

• Environment
• Social
• Governance

Environmental Achievements

• Minimized environmental footprint by outsourcing production and distribution, acknowledging indirect emissions from subcontractors.

Social Achievements

• Improved lives of patients globally through novel cancer treatment, contributing to UN SDG 3.
• Maintained a good working environment with low employee absence due to illness (less than 1%).
• Followed all regulatory requirements for patient safeguarding during clinical trials.
• Aimed to be a workplace providing equal opportunities for all, with women constituting 33% of Board members and 20% of senior management.

Governance Achievements

• Adhered to good corporate governance standards, establishing a Code of Conduct, Insider policy, and Information Policy.
• Ensured compliance with applicable laws relating to ethical and responsible standards of behavior for subcontractors and suppliers, confirming their compliance with the UN Global Compact principles.
• Maintained zero tolerance for corruption.
• Established a GDPR compliance policy for data protection and IT security.

Climate Goals & Targets

Environmental Challenges

• COVID-19 pandemic caused disruption to the pace of patient recruitment in clinical trials.
• Extremely competitive landscape in the immunotherapy and cancer therapeutics industries.

Mitigation Strategies

• Putting all efforts into completing patient enrollment by the end of 2022.
• Identifying additional clinical trial sites in the US and Europe with expertise in intratumoral treatment.

Supply Chain Management

Responsible Procurement

• Exercised caution in partner selection, obtaining confirmation of compliance with applicable laws relating to ethical and responsible standards of behavior, including human rights, labor, environmental protection, sustainable development, and bribery and corruption.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards Core option

UN Sustainable Development Goals

• SDG 3

Improving lives of patients globally through novel cancer treatment.

Environmental Metrics

ESG Focus Areas

• Environment and climate impact
• Product quality and safety
• Supply chain responsibility
• Human rights and human capital
• Business ethics and transparency
• Data protection and IT security
• Access to care

Social Achievements

• Maintained a good working environment with no workplace accidents or injuries, and less than 1% absence due to illness.
• Women constitute 33% of the Board members and 20% of the senior management team.

Governance Achievements

• Established a whistleblowing mechanism.
• Adheres to good corporate governance standards.
• Established an Insider policy and an Information Policy.

Climate Goals & Targets

Environmental Challenges

• Limited impact on the external environment with regards to direct pollution and emissions, as production and distribution activities are outsourced.
• COVID-19 hampered patient enrollment significantly in clinical trials.

Mitigation Strategies

• Expanded the ATLAS-IT-05 trial to Europe to mitigate recruitment challenges experienced in the US as a consequence of COVID-19.
• Outsourced IT infrastructure and support to an external vendor with robust security measures.

Supply Chain Management

Supplier Audits: Periodic audits to confirm compliance with quality and regulatory standards.

Responsible Procurement

• Stringent criteria for supplier selection
• Confirmation that suppliers have adequate systems or policies in place ensuring compliance with applicable laws relating to ethical and responsible standards of behavior.

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• SDG 3: Ensure healthy lives and promote well-being for all at all ages

Improving the lives of patients around the globe through novel cancer treatment.